Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WSL |
Wild boar lung cells | Swine | respiratory system | unknown | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Hübner et al., Scientific Reports, 2018, 8: 1449, DOI:10.1038/s41598-018-19626-1 | Link | ||
WM853 |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | ||
WM266-4 |
Human cutaneous metastatic melanoma cell line | ATTC CRL-1676 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Bubka et al., Biochimie, 2014, 103: 37-49, doi.org/10.1016/j.biochi.2014.04.003 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. M. Davies, PhD Thesis, 2015, University of Dundee | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | E. Fuchs, Julius-Maximilians-Universität Würzburg | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | ||
U138 MG |
Human brain glioblastoma cell line | ATCC HTB-16 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | |
U138 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | E. Fuchs, Julius-Maximilians-Universität Würzburg | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | W. C. Brucker et al., Zurich Open Repository and Archive, University of Zurich, 2012, doi.org/10.1038/onc.2011.530 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C. Wanka et al., J. Biol. Chem., Sep 2012; 287: 33436 - 33446 | Link | |
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S.-B. M. Varda et al., 2012, WO 2007/043049 | Link | ||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Pichorner, Dissertation, 2012 , Charité – Universitätsmedizin Berlin | Link | |
SV40 MES 13 |
Mouse mesangial cell line | ATCC CRL1927 | Mouse | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. Neuhofer et al., Frontiers in Physiol., 5 , article 123, doi: 10.3389/fphys.2014.00123 | Link | |
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | O. Gires et al., Anticancer Res, Nov 2004; 24: 3715 - 3722 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | D. Haslinger et al., Mol. Autism, 2018, 9:56, doi.org/10.1186/s13229-018-0239-z | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. C. Hogg et al., Brain Commun., 2020, 1 of 17, doi:10.1093/braincomms/fcaa138 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. M. Danzer et al., J. Neurosci., Aug 2007; 27: 9220 - 9232 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | C. Lenzi et al., Int. J. Mol. Sci., 2020, 21, 7181, doi:10.3390/ijms21197181 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | F. Walter et al., Cell Death and Differentiation, 2015, 22: 1502-1516; doi:10.1038/cdd.2014.241 | Link |